Enzo Announces Issuance of U.S. Patent for Methods of Producing Monoclonal Antibodies Against Osteoporosis Drug Target Sclerostin

Stock Information for Enzo Biochem Inc. ($0.01 Par Value)

Loading

Please wait while we load your information from QuoteMedia.